Literature DB >> 21360304

A mouse model for spatial and temporal expression of HGF in the heart.

Ilan Riess1, Valentina Sala, Christian Leo, Marco Demaria, Stefano Gatti, Simona Gallo, Amandine Fitou, Ombretta Boero, Renzo Levi, Ivan Cuccovillo, Fabiola Molla, Noeleen De Angelis, Lidia Staszewsky, Roberto Latini, Tiziana Crepaldi.   

Abstract

In order to study the effects of Hepatocyte Growth Factor (HGF) in the heart, two transgenic mice were developed, one carrying a bidirectional HGF-TetO-GFP responder construct and the other carrying a α-MHC-tTA transactivator construct. Crosses were carried out between heterozygotes, so that litters contained bitransgenic α-MHC-tTA/HGF-TetO-GFP+, thus expressing HGF and GFP exclusively in the heart and only in the absence of Doxycycline. Our data show that the expression of HGF was indeed restricted to the heart and that the expression was limited to the timeframe of the absence of Doxycycline. Surprisingly the expression was variable even between bitransgenic littermates. In the setting of a model of ischemia-reperfusion, the expression of HGF ameliorates cardiac functionality, enhances proliferation and diminishes the scarred area, proving that this is a good model to study the beneficial influences and functional roles of HGF in the heart.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360304     DOI: 10.1007/s11248-011-9485-y

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  31 in total

Review 1.  Met, metastasis, motility and more.

Authors:  Carmen Birchmeier; Walter Birchmeier; Ermanno Gherardi; George F Vande Woude
Journal:  Nat Rev Mol Cell Biol       Date:  2003-12       Impact factor: 94.444

Review 2.  Timing is everything in life: conditional transgene expression in the cardiovascular system.

Authors:  G I Fishman
Journal:  Circ Res       Date:  1998-05-04       Impact factor: 17.367

3.  Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart.

Authors:  H Ueda; Y Sawa; K Matsumoto; S Kitagawa-Sakakida; Y Kawahira; T Nakamura; Y Kaneda; H Matsuda
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

4.  A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats.

Authors:  H Ueda; T Nakamura; K Matsumoto; Y Sawa; H Matsuda; T Nakamura
Journal:  Cardiovasc Res       Date:  2001-07       Impact factor: 10.787

5.  Sustained preconditioning induced by cardiac transgenesis with the tetracycline transactivator.

Authors:  Lynne Turnbull; Hui-Zhong Zhou; Philip M Swigart; Sally Turcato; Joel S Karliner; Bruce R Conklin; Paul C Simpson; Anthony J Baker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-21       Impact factor: 4.733

6.  Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.

Authors:  Yigang Wang; Nauman Ahmad; Maqsood A Wani; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2004-11       Impact factor: 5.000

7.  Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.

Authors:  M Aoki; R Morishita; Y Taniyama; I Kida; A Moriguchi; K Matsumoto; T Nakamura; Y Kaneda; J Higaki; T Ogihara
Journal:  Gene Ther       Date:  2000-03       Impact factor: 5.250

8.  Overexpression of the transcription factor Hand1 causes predisposition towards arrhythmia in mice.

Authors:  Ross A Breckenridge; Zia Zuberi; John Gomes; Robert Orford; Laurent Dupays; Leanne E Felkin; James E Clark; Anthony I Magee; Elisabeth Ehler; Emma J Birks; Paul J R Barton; Andrew Tinker; Timothy J Mohun
Journal:  J Mol Cell Cardiol       Date:  2009-04-17       Impact factor: 5.000

9.  Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner.

Authors:  Anice Moumen; Alessandro Ieraci; Salvatore Patané; Carme Solé; Joan X Comella; Rosanna Dono; Flavio Maina
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

10.  Conditional activation of MET in differentiated skeletal muscle induces atrophy.

Authors:  Tiziana Crepaldi; Francesca Bersani; Claudio Scuoppo; Paolo Accornero; Chiara Prunotto; Riccardo Taulli; Paolo E Forni; Christian Leo; Roberto Chiarle; Jennifer Griffiths; David J Glass; Carola Ponzetto
Journal:  J Biol Chem       Date:  2006-12-27       Impact factor: 5.157

View more
  4 in total

1.  Gene expression profiling of HGF/Met activation in neonatal mouse heart.

Authors:  Stefano Gatti; Christian Leo; Simona Gallo; Valentina Sala; Enrico Bucci; Massimo Natale; Daniela Cantarella; Enzo Medico; Tiziana Crepaldi
Journal:  Transgenic Res       Date:  2012-12-06       Impact factor: 2.788

Review 2.  HGF/Met Axis in Heart Function and Cardioprotection.

Authors:  Simona Gallo; Valentina Sala; Stefano Gatti; Tiziana Crepaldi
Journal:  Biomedicines       Date:  2014-10-21

3.  TGFβ1 and HGF regulate CTGF expression in human atrial fibroblasts and are involved in atrial remodelling in patients with rheumatic heart disease.

Authors:  Jian-Quan Chen; Yan-Song Guo; Qian Chen; Xian-Lu Cheng; Guo-Jian Xiang; Mei-Yan Chen; Hong-Lin Wu; Qi-Lei Huang; Peng-Li Zhu; Jian-Cheng Zhang
Journal:  J Cell Mol Med       Date:  2019-01-29       Impact factor: 5.310

4.  Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy.

Authors:  S Gallo; S Gatti; V Sala; R Albano; P Costelli; E Casanova; P M Comoglio; T Crepaldi
Journal:  Cell Death Dis       Date:  2014-04-17       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.